Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ABL1 Antikörper (AA 550-600)

ABL1 Reaktivität: Human WB, IHC, IF, IHC (p), ICC, IP, PLA Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN1890708
  • Target Alle ABL1 Antikörper anzeigen
    ABL1 (C-Abl Oncogene 1, Non-Receptor tyrosine Kinase (ABL1))
    Bindungsspezifität
    • 37
    • 33
    • 21
    • 20
    • 16
    • 15
    • 15
    • 15
    • 15
    • 15
    • 15
    • 15
    • 15
    • 12
    • 12
    • 9
    • 9
    • 7
    • 6
    • 6
    • 5
    • 5
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 550-600
    Reaktivität
    • 256
    • 142
    • 108
    • 14
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 339
    • 3
    Kaninchen
    Klonalität
    • 339
    • 3
    Polyklonal
    Konjugat
    • 112
    • 25
    • 23
    • 21
    • 14
    • 14
    • 14
    • 14
    • 14
    • 14
    • 11
    • 11
    • 11
    • 11
    • 11
    • 11
    • 11
    Dieser ABL1 Antikörper ist unkonjugiert
    Applikation
    • 224
    • 143
    • 143
    • 142
    • 76
    • 57
    • 33
    • 33
    • 28
    • 16
    • 10
    • 3
    • 3
    • 2
    • 2
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC), Immunoprecipitation (IP), Proximity Ligation Assay (PLA)
    Spezifität
    Region between residue 550 and 600 of human v-abl Abelson murine leukemia viral oncogene homolog 1 using the numbering given in entry NP_005148.2 (GeneID 25).
    Aufreinigung
    Immunoaffinity purified
    Isotyp
    IgG
    Top Product
    Discover our top product ABL1 Primärantikörper
  • Applikationshinweise
    Approved: ICC (1:100 - 1:1000), IF (1:100 - 1:1000), IHC, IHC-P (1:100 - 1:1000), IP (2 - 5 μg/mg lysate), PLA (1:200 - 1:4000), WB (1:2000 - 1:10000)

    Usage: Immunohistochemistry: Antigen retrieval with citrate buffer  pH 6.0 is recommended for FFPE tissue sections. Human controls: K562 Cells, Ovarian Carcinoma, Prostate Carcinoma.
    Kommentare

    Target Species of Antibody: Human

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    Lot specific
    Buffer
    Tris-buffered saline, 0.1 % BSA, 0.09 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C
    Informationen zur Lagerung
    Store at 2-8°C for up to 1 year.
    Haltbarkeit
    12 months
  • Target
    ABL1 (C-Abl Oncogene 1, Non-Receptor tyrosine Kinase (ABL1))
    Andere Bezeichnung
    ABL1 / C-ABL (ABL1 Produkte)
    Synonyme
    ABL antikoerper, JTK7 antikoerper, bcr/abl antikoerper, c-ABL antikoerper, p150 antikoerper, v-abl antikoerper, AI325092 antikoerper, Abl antikoerper, E430008G22Rik antikoerper, c-Abl antikoerper, ABL proto-oncogene 1, non-receptor tyrosine kinase antikoerper, c-abl oncogene 1, non-receptor tyrosine kinase antikoerper, Tyrosine-protein kinase abl-1 antikoerper, ABL1 antikoerper, Abl1 antikoerper, abl-1 antikoerper, abl1 antikoerper
    Hintergrund
    Name/Gene ID: ABL1
    Subfamily: Abl
    Family: Protein Kinase

    Synonyms: ABL1, Bcr/c-abl oncogene protein, Bcr-Abl, Bcr/abl, C-ABL, ABL, JTK7, p150, Tyrosine-protein kinase ABL1, Proto-oncogene c-Abl, V-abl
    Gen-ID
    25
    Pathways
    Apoptose, Regulation of Muscle Cell Differentiation, Platelet-derived growth Factor Receptor Signaling, Lipid Metabolism
Sie sind hier:
Kundenservice